scholarly journals Prescription Pattern of Chinese Herbal Products for Breast Cancer in Taiwan: A Population-Based Study

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Jung-Nien Lai ◽  
Chien-Tung Wu ◽  
Jung-Der Wang
Keyword(s):  
Breast Cancer ◽  
Panax Ginseng ◽  
Synergistic Effects ◽  
Symptom Relief ◽  
Healthcare Providers ◽  
Angelica Sinensis ◽  
Research Database ◽  
Herbal Products ◽  
Chinese Herbal ◽  
Angelica Sinensis Radix

Background. Chinese herbal products (CHPs) given as a therapy for symptom relief have gained widespread popularity among women with breast cancer. The aim of this study was to analyze the utilization of CHP among women with breast cancer in Taiwan.Methods. The usage, frequency of services, and CHP prescribed for breast cancer among women with breast cancer were evaluated, recruited from a randomly sampled cohort of 1,000,000 beneficiaries from the National Health Insurance Research Database. The logistic regression method was employed to estimate the odds ratios (ORs) for utilization of CHP.Results. 81.5 percent (N=2,236) of women with breast cancer utilized traditional Chinese medicine (TCM) and 18% of them sought TCM with the intent of treating their breast cancer. Jia-wei-xiao-yao-san (Augmented Rambling Powder) was the most frequently prescribed formula for treating breast cancer. Among the top 10 most frequently prescribed CHP for treating breast cancer, seven contained dang qui (Angelica sinensis-radix) and six contained ren shen (Panax ginseng-radix), which are reported to have potential beneficial synergistic effects on breast cancer cells.Conclusion. CHP containing dang qui (Angelica sinensis-radix) or ren shen (Panax ginseng-radix) are the most frequently prescribed for breast cancer and their effects should be taken into account by healthcare providers.

scholarly journals The Traditional Chinese Medicine Prescription Pattern of Endometriosis Patients in Taiwan: A Population-Based Study

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Ruei-Chi Fang ◽  
Yueh-Ting Tsai ◽  
Jung-Nien Lai ◽  
Chia-Hao Yeh ◽  
Chien-Tung Wu
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Symptom Relief ◽  
Healthcare Providers ◽  
Population Based ◽  
Reproductive Age ◽  
Research Database ◽  
Herbal Products ◽  
Chinese Herbal ◽  
Medicine Prescription

Background. Traditional Chinese medicine (TCM), when given for symptom relief, has gained widespread popularity among women with endometriosis. The aim of this study was to analyze the utilization of TCM among women with endometriosis in Taiwan.Methods. The usage, frequency of service, and the Chinese herbal products prescribed for endometriosis, among endometriosis patients, were evaluated using a randomly sampled cohort of 1,000,000 beneficiaries recruited from the National Health Insurance Research Database.Results. Overall, 90.8% (N=12,788) of reproductive age women with endometriosis utilized TCM and 25.2% of them sought TCM with the intention of treating their endometriosis-related symptoms. Apart from the usage of either analgesics or more than one type of medical treatment, the odds of using TCM and Western medicine were similar in all types of conventional endometriosis treatment. However, endometriosis patients suffering from symptoms associated with endometriosis were more likely to seek TCM treatment than those with no symptoms. There were 21,056 TCM visits due to endometriosis and its related symptoms, of which more than 98% were treated with Chinese herbal products (CHPs).Conclusion.Gui-Zhi-Fu-Ling-Wan(Cinnamon Twig and Poria Pill) containing sedative and anti-inflammatory agents is the most commonly prescribed Chinese herbal formula mainly for the treatment of endometriosis-related symptomatic discomfort and the effects of these TCMs should be taken into account by healthcare providers.

scholarly journals The Prescription Pattern of Chinese Herbal Products ContainingGinsengamong Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based Study

2015 ◽  
Vol 2015 ◽  
pp. 1-11 ◽  
Author(s):  
Wei-Lung Hsu ◽  
Yueh-Ting Tsai ◽  
Chien-Tung Wu ◽  
Jung-Nien Lai
Keyword(s):  
Breast Cancer ◽  
Endometrial Cancer ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Population Based ◽  
Interactive Effects ◽  
Tamoxifen Treatment ◽  
Research Database ◽  
Herbal Products ◽  
Chinese Herbal

Background.The purpose of our study is to analyze the association between prescribed Chinese herbal products (CHPs) containingGinsengand the risk of endometrial cancer among tamoxifen (TMX) users and to identify any possible interactive effects betweenGinsengand TMX with respect to preventing the development of subsequent endometrial cancer in an estrogen-dependent breast cancer population in Taiwan.Methods.All patients newly diagnosed with invasive breast cancer receiving tamoxifen treatment from January 1, 1998, to December 31, 2008, were selected from the National Health Insurance Research Database. The usage, frequency of service, and CHP-Ginsengprescribed across the 30,556 TMX-treated breast cancer (BC) survivors were evaluated. Logistic regression was employed to estimate the odds ratios (ORs) for the utilization of CHP-Ginseng. Cox’s proportional hazard regression was performed to calculate the hazard ratios (HRs) for endometrial cancer associated withGinsenguse among the TMX-treated BC cohort.Results.The HR for the development of endometrial cancer among breast cancer survivors who had ever takenGinsengafter TXM treatment was significantly decreased compared to those who never used CHP.Conclusion.A significant inhibitory relationship betweenGinsengconsumption and subsequent endometrial cancer less than 2 years after TMX treatment was detected among BC survivors.

scholarly journals Concurrent Use in Taiwan of Chinese Herbal Medicine Therapies among Hormone Users Aged 55 Years to 79 Years and Its Association with Breast Cancer Risk: A Population-Based Study

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Yueh-Ting Tsai ◽  
Jung-Nien Lai ◽  
Chien-Tung Wu ◽  
Shun-Ku Lin
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Risk ◽  
Cancer Risk ◽  
Proportional Hazards ◽  
Population Based ◽  
Cox Proportional Hazards ◽  
Research Database ◽  
Herbal Products ◽  
Chinese Herbal ◽  
Concurrent Use

Background. The purpose of the present study was to analyze the concurrent use of Chinese herbal products (CHPs) among women aged 55 to 79 years who had also been prescribed hormonal therapies (HT) and its association with breast cancer risk.Methods. The use, frequency of service, and CHP prescribed among 17,583 HT users were evaluated from a random sample of 1 million beneficiaries from the National Health Insurance Research Database. A logistic regression method was used to identify the factors that were associated with the coprescription of a CHP and HT. Cox proportional hazards regressions were performed to calculate the hazard ratios (HRs) of breast cancer between the TCM nonusers and women who had undergone coadministration of HT and a CHP or CHPs.Results. More than one out of every five study subjects used a CHP concurrently with HT (CHTCHP patients).Shu-Jing-Huo-Xie-Tangwas the most commonly used CHP coadministered with HT. In comparison to HT-alone users, the HRs for invasive breast cancer among CHTCHP patients were not significantly increased either in E-alone group or in mixed regimen group.Conclusions. The coadministration of hormone regimen and CHPs did not increase the risk of breast cancer.

scholarly journals Chinese Herbal Medicine as an Adjunctive Therapy Ameliorated the Incidence of Chronic Hepatitis in Patients with Breast Cancer: A Nationwide Population-Based Cohort Study

2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
Kuo-Chin Huang ◽  
Hung-Rong Yen ◽  
Jen-Huai Chiang ◽  
Yuan-Chih Su ◽  
Mao-Feng Sun ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Chronic Hepatitis ◽  
Cohort Study ◽  
Herbal Medicine ◽  
Incidence Rate ◽  
Chinese Herbal Medicine ◽  
Therapeutic Potential ◽  
Population Based ◽  
Research Database ◽  
Chinese Herbal

We conducted a National Health Insurance Research Database-based Taiwanese nationwide population-based cohort study to evaluate whether Chinese herbal medicine (CHM) treatment decreased the incidence of chronic hepatitis in breast cancer patients receiving chemotherapy and/or radiotherapy. A total of 81171 patients were diagnosed with breast cancer within the defined study period. After randomly equal matching, data from 13856 patients were analyzed. Hazard ratios of incidence rate of chronic hepatitis were used to determine the influence and therapeutic potential of CHM in patients with breast cancer. The patients with breast cancer receiving CHM treatment exhibited a significantly decreased incidence rate of chronic hepatitis even across the stratification of age, CCI score, and treatments. The cumulative incidence of chronic hepatitis for a period of seven years after initial breast cancer diagnosis was also reduced in the patients receiving CHM treatment. The ten most commonly used single herbs and formulas were effective in protecting liver function in patients with breast cancer, where Hedyotis diffusa and Jia-Wei-Xiao-Yao-San were the most commonly used herbal agents. In conclusion, our study provided information that western medicine therapy combined with CHM as an adjuvant modality may have a significant impact on liver protection in patients with breast cancer.

scholarly journals Chinese herbal products and the reduction of risk of breast cancer among females with type 2 diabetes in Taiwan

Medicine ◽  
2018 ◽  
Vol 97 (31) ◽  
pp. e11600 ◽  
Author(s):  
Chien-Tung Wu ◽  
Yueh-Ting Tsai ◽  
Jaung-Geng Lin ◽  
Shu-ling Fu ◽  
Jung-Nien Lai
Keyword(s):  
Breast Cancer ◽  
Type 2 Diabetes ◽  
Herbal Products ◽  
Chinese Herbal

scholarly journals Prescription of Chinese herbal products is associated with a decreased risk of invasive breast cancer

Medicine ◽  
2017 ◽  
Vol 96 (35) ◽  
pp. e7918 ◽  
Author(s):  
Yueh-Ting Tsai ◽  
Jung-Nien Lai ◽  
Pei-Chia Lo ◽  
Chin-Nu Chen ◽  
Jaung-Geng Lin
Keyword(s):  
Breast Cancer ◽  
Invasive Breast Cancer ◽  
Herbal Products ◽  
Chinese Herbal
Sign in / Sign up

Export Citation Format

Share Document